<DOC>
	<DOC>NCT01669460</DOC>
	<brief_summary>The purpose of this research study is to find out if Red Bull™ Sugar-Free Drink can reduce fatigue in prostate cancer patients receiving LHRH agonist therapy.</brief_summary>
	<brief_title>Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Histologically confirmed prostate cancer Currently receiving LHRHagonist therapy for greater than 6 months Measurable fatigue, defined as a score of ≥ 2 on the Bruera global fatigue severity scale Able to swallow Red Bull™ SugarFree Drink Life expectancy of at least 1 year Able to read and write in English Willing to limit consumption of alcohol to one drink per day Current malignancy or received treatment for a previous malignancy within the last 3 years other than prostate cancer (exceptions are superficial bladder cancer or nonmelanoma skin cancer) Myocardial infarction within past 6 months Any unstable serious coexisting medical condition(s) including but not limited to unstable or poorly controlled coronary artery disease, chronic atrial fibrillation, uncontrolled hypertension, uncontrolled diabetes, severe bleeding diseases or immune disorders Evidence of drug or alcohol abuse Known hypersensitivity to caffeine Known history of liver and kidney insufficiencies Known contraindications to Red Bull™ use</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>